A therapeutic effect of rapamycin on aortopathies has been reported in mice with Tgfbr2 disruption in postnatal SMCs, a model of Loeys-Dietz syndrome [23]. The gene discussed is TGFBR2; the disease is Loeys-Dietz syndrome.